Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

940 Results

Document

Ontario-Cervical-Screening-Program-Recommendations-for-Cervical-Screening-and-Colposcopy-with-HPV-testing.pdf

Feb 2025

Document

Ontario-Cervical-Screening-Program-Transition-Guidance-for-ages-21-24.pdf

Feb 2025

Document

Ontario-Cervical-Screening-Program-Guidance-for-Vaginal-Vault-Testing.pdf

Feb 2025

Ontario Cervical Screening Program

Suivi des tests de dépistage autoprélevés du virus du papillome humain (VPH)

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Status: Current

Mar 2025

Drug

siltuximab

Other Name(s): Sylvant®

Quick Link(s): Drug Monograph, Patient Info Sheet

Mar 2025

Regimen

SILT

Cancer Type:

Hematologic,

Rare Diseases

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Funding:

New Drug Funding Program

Siltuximab - Multicentric Castleman’s Disease (MCD)

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Mar 2025

Services cliniques

Les programmes cliniques d’Action Cancer Ontario sont mis en œuvre en collaboration avec les cliniciens des Programmes régionaux de cancérologie en...

Document

OCS2024.pdf

Mar 2025

Pages